Overview
- 70 inspections across 58 sites are on record.
- 72 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-07-18.
At a glance
Inspections
70
Sites
58
Observations
72
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| McKesson Corporation Headquarters | 18 Jul 2018 | Human Drugs | On file |
| Biocompatibles UK Ltd | 3 Jul 2015 | Human Drugs | On file |
| TriRx Segre | 22 Jun 2015 | Human Drugs | On file |
| Hamamatsu / Queens PET Imaging Center, LLC | 14 May 2015 | Human Drugs | On file |
| Allergan Sales, LLC | 20 Apr 2015 | Human Drugs | On file |
Sites inspected
McKesson Corporation HeadquartersSan Francisco, United States1 insp.
Biocompatibles UK LtdFarnham, United Kingdom1 insp.
TriRx SegreSegre-En-Anjou Bleu, France1 insp.
Hamamatsu / Queens PET Imaging Center, LLCHonolulu, United States1 insp.
Allergan Sales, LLCCampbell, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
William V Millar4 shared
Stephanie A Slater3 shared
Daniel J Roberts3 shared
Jennifer H Rhyu2 shared
Henry K Lau2 shared
Mark E Chan2 shared
Marie K Kinkade2 shared
Peter E Baker2 shared
Jeffrey M Watson2 shared
Sharon K Thoma2 shared
Full investigator report
Get the verbatim findings behind Lance M De Souza's 72 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site